| |
|
|
Session 94
Poster Presentations Pathogenesis and Mechanisms of Lipodystrophy Syndromes Thursday 1:30 - 3:30 pm Hall B |
| 753 | Mechanism of Dyslipidaemia in HIV-infected Adults S. Das*1, M. Stolinski2, W. Jefferson2, N. Jackson2, G. Gilleran3, R. Cramb4, M. Umpleby5, M. Shahmanesh6 1Specialist Registrar, Birmingham, UK; 2Res Fellow, London, UK; 3Res Nurse, Birmingham, UK; 4Consultant Endocrinologist, Birmingham, UK; 5Reader, Human Metabolism, London, UK; and 6Consultant Physician, Birmingham, UK |
| 754 | Serum Adipocytokines are Related to Lipodystrophy and Metabolic Alterations in HIV-infected Men Under PI-Based HAART C. Vigouroux1,2, M. Maachi1,2, T-H. Nguyen1, C. Coussieu3, S. Gharakhanian1, T. Funahashi4, Y. Matsuzawa4, I. Shimomura4, W. Rozenbaum1, J. Capeau*1,2, J-P. Bastard1,2 1Tenon Hosp, Paris, France; 2INSERM U 402, Paris, France; 3Hôtel-Dieu Hosp, Paris, France; and 4Osaka Univ, Japan |
| 755 | Effects of HAART on Expression (mRNA) of PPAR- C. Pace1, A. Martin1, C. Mamotte2, E.Hammond*1, D. Nolan1, S. Mallal1 1Ctr for Clin Immunology and BioMed Statistics, Western Australia and 2Royal Perth Hosp, Australia |
| 756 | Adipocytokine Levels in the Lipodystrophy Syndrome of HIV-infected Patients W. L. Dinges*1, D. Chen1, I. Shimomura2, Y. Matsuzawa2, D. M. Peterson1, A. Garg1 1Univ of Texas Southwestern Med Ctr, Dallas and 2Osaka Univ, Japan |
| 757 | Impaired Insulin Sensitivity in HIV-infected Individuals is Associated with Higher Hepatic Lipid Content and Visceral Adiposity K. Yarasheski*, D. Reeds, J. Schulte, E. Zinna, S. Claxton, S. Mohammed, D. Yablonskiy, L. Bretthorst, W. Powderly, S. Klein Washington Univ, St Louis, MO |
| 758 | Impaired Gene Expression in Adipose Tissue of HIV Subjects Undergoing HAART, Affected by Severe Lipodystrophy A. Napolitano*, I. Marchetti, R. Guttmann, P. Ferrari, J. L. Sadoul, P. Dellamonica, J. Durant CHU Archet, Nice, France |
| 759 | Evidence of Toxicity in Adipose Tissue of HIV-infected Patients Correlates with NRTI-associated mtDNA Depletion E. Hammond*1, D. Nolan1, I. James1, E. McKinnon1, A. White2, S. Mallal1 1Ctr for Clin Immunology and BioMed Statistics, Western Australia and 2GlaxoSmithKline, UK |
| 760 | Evaluation of the Oxidative Metabolism in Skeletal Muscle Using Carbon-11 Acetat PET in HIV-infected Patients with Lipodystrophy Syndrome G. M. N. Behrens*1,2, A-R. Boerner1, K. Weber1, J. van den Hoff1, J. Ockenga1, G. Brabant1, R. E. Schmidt1 1Hannover Med Sch, Germany and 2Walter and Eliza Hall Inst, Melbourne, Australia |
| 761 | Absence of Sustained Hyperlactatemia Among HIV-infected Patients with Risk Factors for Mitochondrial Toxicity D. A. Wohl*1, C. D. Pilcher1, M. Revuelta2, G. McComsey 3, S. L. Koletar 4, S. Evans 5, Y. Yijun 5, R. Zackin 5, B. Alston 6, S. Welch 7, M. Basar8, A. Kashuba1, P. Kondo9, J. Quinn 10, H. Wingfield11 1Univ of North Carolina, Chapel Hill; 2Beth Israel Med Ctr, New York, NY; 3Case Western Reserve Univ, Cleveland, OH; 4Ohio State Univ, Columbus; 5Harvard Sch of Public Hlth, Boston, MA; 6Natl Inst of Hlth, Bethesda, MD; 7Social and Sci Sys, Silver Spring, MD; 8Frontier Sci and Tech Res Fndn, Amherst, NY; 9Univ of Hawaii, Honolulu; 10Univ of Pennsylvania, Philadelphia; and 11Univ of Alabama at Birmingham |
| 762 | Mitochondrial Membrane Potential and HAART-associated Lactic Acidosis P. V. Nerurkar*, L. Pearson, J. E. Frank, R. Yanagihara, V. R. Nerurkar Univ of Hawaii, Honolulu |
| 763 | Evidence Suggesting Mitochondrial Toxicity in HIV/HCV Co-infected Patients Receiving Ribavirin and Didanosine R. Fleischer*1, D. Boxwell1, K. E. Sherman2 1FDA, Rockville, MD and 2Univ of Cincinnati, OH |
| 764 | Bone Loss Is Closely Related to Fat Loss in HIV-infected Patients Receiving Antiretroviral Treatment G. Tsekes*1, D. Paraskeva1, G. Douskas2, M. Chini1, N. Mangafas1, M. Boboli1, E. Georgiou3, M. C. Lazanas1 1Red Cross Hosp, Athens, Greece; 2Hygias Melathron, Athens, Greece; and 3Athens Univ Med Sch, Greece |